lipedema semaglutide Learn About the Ozempic 📣 Experts have spoken and

The real decision is not just Zepbound vs Wegovy

By activating GIP receptors, tirzepatide enhances insulin secretion

Tommy Acciani 07:55 Its a great question

Pancreatitis There has been ongoing debate about the risk of pancreatitis with GLP-1 agonists

The primary risk factors include: Chronic constipation and straining during bowel movements Prolonged sitting on the toilet Diarrhoea (less commonly, but repeated episodes can contribute) Increased intra-abdominal pressure Given that Wegovy causes constipation in approximately 24% of users, patients who develop this side effect may experience harder stools and increased straining during defecation

Retatrutide, a triple GLP-1/GIP/glucagon receptor agonist, represents the next evolutionary step